🔎 Trials Near Me

Nyumbani › Burkitt Lymphoma

Majaribio ya kliniki ya Burkitt Lymphoma yanayovutia washiriki nchini Marekani

Masomo 63 ya Burkitt Lymphoma yanavutia washiriki katika vituo vya Marekani nzima.

Miji yenye masomo mengi

Kwa jimbo

Masomo yaliyosasishwa hivi karibuni

Maandishi rasmi ya utafiti (Kiingereza)

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

InaajiriHatua 3
Umri 18 hadi 39 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT03150693

Blinatumomab Consolidation in Real World

InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT07117136

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

InaajiriUtafiti wa uchunguzi
Umri 0 hadi 38 · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT06131801

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

InaajiriHatua 1/2
Umri 18 hadi 120 · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT03223610

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06144606

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

InaajiriHatua 3
Umri 1 na zaidi · Jinsia zote · Imesasishwa 17 Sep 2026 · NCT07223021

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

InaajiriHatua 1/2
31 Days – 30 Years · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT04544592

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

InaajiriHatua 1
Umri 18 hadi 120 · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT05389423

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

InaajiriHatua 3
365 Days – 25 Years · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

InaajiriHatua 2
Umri 7 hadi 25 · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT05082519

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

InaajiriHatua 1/2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT06137118

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 12 Ago 2026 · NCT06340737

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

InaajiriHatua 1/2
Umri 13 hadi 90 · Jinsia zote · Imesasishwa 6 Ago 2026 · NCT06533579

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.